Justin (Matt) Thomas
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Justin (Matt) Thomas sits in the upper half of US sponsors by registered trial count (#7,390 of 15,751 sponsors by registered trial count).
Justin (Matt) Thomas: 1 sponsored US clinical trial, 1 recruiting.
Justin (Matt) Thomas sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Type 2 Diabetes, with 1 trials.
Mid-pack sponsor footprint
Justin (Matt) Thomas is in the upper half of sponsors by trial count (#7,390 of 15,751 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Open and recent trials
1 total, page 1 of 1
Therapeutic Areas
What is open in the Justin (Matt) Thomas pipeline
1 recruiting of 1 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Type 2 Diabetes (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.